Nationwide Fund Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-29,130
| Closed | -$803K | – | 2224 |
|
|
2017
Q3 | $803K | Sell |
29,130
-600
| -2% | -$16.5K | ﹤0.01% | 1926 |
|
|
2017
Q2 | $785K | Buy |
29,730
+3,300
| +12% | +$87.1K | ﹤0.01% | 1925 |
|
|
2017
Q1 | $550K | Sell |
26,430
-3,547
| -12% | -$73.8K | ﹤0.01% | 2112 |
|
|
2016
Q4 | $621K | Sell |
29,977
-1,579
| -5% | -$32.7K | ﹤0.01% | 2054 |
|
|
2016
Q3 | $512K | Sell |
31,556
-2,000
| -6% | -$32.5K | ﹤0.01% | 2167 |
|
|
2016
Q2 | $456K | Buy |
33,556
+16,477
| +96% | +$224K | ﹤0.01% | 2203 |
|
|
2016
Q1 | $298K | Buy |
17,079
+201
| +1% | +$3.51K | ﹤0.01% | 2349 |
|
|
2015
Q4 | $577K | Buy |
16,878
+1,497
| +10% | +$51.2K | ﹤0.01% | 2037 |
|
|
2015
Q3 | $458K | Hold |
15,381
| – | – | ﹤0.01% | 2165 |
|
|
2015
Q2 | $492K | Sell |
15,381
-464
| -3% | -$14.8K | ﹤0.01% | 2257 |
|
|
2015
Q1 | $328K | Sell |
15,845
-2,714
| -15% | -$56.2K | ﹤0.01% | 2454 |
|
|
2014
Q4 | $314K | Sell |
18,559
-591
| -3% | -$10K | ﹤0.01% | 2436 |
|
|
2014
Q3 | $370K | Buy |
19,150
+1,120
| +6% | +$21.6K | ﹤0.01% | 2386 |
|
|
2014
Q2 | $613K | Buy |
18,030
+2,912
| +19% | +$99K | ﹤0.01% | 2148 |
|
|
2014
Q1 | $476K | Buy |
+15,118
| New | +$476K | ﹤0.01% | 2081 |
|